Genomic Valley Biotech Limited (BOM:539206)

Market Cap	81.71M -57.0%
Revenue (ttm)	4.94M -15.0%
Net Income	-359.58K
EPS	-0.12
Shares Out	3.05M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,414
Average Volume	840
Open	26.15
Previous Close	n/a
Day's Range	26.15 - 28.90
52-Week Range	20.10 - 64.00
Beta	-0.12
RSI	55.90
Earnings Date	May 11, 2026

About Genomic Valley Biotech

Genomic Valley Biotech Limited operates in horticulture business activities in India. The company involved in the commercial greenhouse/poly house cultivation of crops; commercial horticulture activities with aloe vera, tomato, bitter gourd, bottle gourd, brinjal, broccoli, cabbage, capsicum, carrot, cauliflower, cucumber, green chilies, onion, radish, ridge/sponge gourd, leafy vegetables, pumpkin, banana, guava, papaya, and strawberry; and commercial floriculture of flowers. It undertakes contracts for its clients for erecting greenhouses; and...

• Industry: Agricultural Production Crops
• Founded: 1994
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539206

Financial Performance

In fiscal year 2025, Genomic Valley Biotech's revenue was 8.44 million, an increase of 411.25% compared to the previous year's 1.65 million. Earnings were 3.56 million, an increase of 2245.53%.